HROW Q3 2018 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11M+65.6% YoY

Gross Profit

$7M61.0% margin

Operating Income

-$649,000-6.0% margin

Net Income

-$3M-23.4% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

$323,000

Free Cash Flow

-$324,000

Stock-Based Comp.

$591,000

Balance Sheet

Total Assets

$28M

Total Liabilities

$24M

Stockholders' Equity

$4M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$6M	+65.6%
Gross Profit	$7M	$3M	+112.6%
Operating Income	-$649,000	-$3M	+76.5%
Net Income	-$3M	-$6M	+55.8%

Revenue Segments

License Revenues

$10,000100%